miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition
Discover Oncology · 25.06.2024 · 15 (1)
DOI: 10.1007/s12672-024-01106-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 25.06.2024. Verfasst von Ying Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Harbin, 150081, Heilongjiang, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China.
Abstract (Originalsprache)
Background miR-200a-3p is involved in the progression of malignant behavior in various tumors, and its mechanism of action in endometrial cancer is speculated to be related to epithelial-mesenchymal transition (EMT). Therefore, this study explored the metastatic mechanism of miR-200a-3p and EMT in endometrial cancer, with the aim of identifying potential therapeutic targets. Methods qRT-PCR was used to analyze miR-200a-3p expression in HEC-1B and Ishikawa cell lines. The cell proliferation assay, transwell assay, and cell scratch test were used to assess changes in the malignant phenotypes of cells after regulating miR-200a-3p expression. Changes in EMT-related protein zinc finger E-box binding homeobox 1 (ZEB1) were detected after regulating miR-200a-3p expression. An endometrial carcinoma transplantation mouse tumor model was constructed, and multiple EMT-related proteins were examined.
Results
The expression of miR-200a-3p and ZEB1 in the endometrial cancer cell lines was higher than in normal endometrial epithelial cell lines (P < 0.05). After silencing miR-200a-3p, the expression of EMT-related protein ZEB1 increased, indicating a negative correlation. Simultaneously, the proliferation, invasion, and metastasis of endometrial cancer cells were significantly enhanced. After miR-200a-3p overexpression, the corresponding malignant phenotype was reversed (P < 0.05). In in vivo experiments, the degree of tumor malignancy and the expression level of EMT-related proteins were significantly reduced in the miR-200a-3p mimic group (P < 0.05).
Conclusion
This study found that miR-200a-3p is a promising target, regulating the EMT process and promoting endometrial cancer progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Harbin, 150081, Heilongjiang, China.
- Department of Hygienic Microbiology, Public Health College, Harbin Medical University, No. 157 Baojian Road, Harbin, 150081, Heilongjiang, China. dongtuo@hrbmu.edu.cn.
- Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Harbin, 150081, Heilongjiang, China. 1427@hrbmu.edu.cn.
Förderung
- Natural Science Foundation of China
Zitieren
APA
Ma, Y., Wang, Y., Wang, C., Wang, Y., Hu, J., Zhang, Z., Dong, T., & Chen, X. (2024). miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01106-w
Vancouver
Ma Y, Wang Y, Wang C, Wang Y, Hu J, Zhang Z, et al. miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01106-w
BibTeX
@article{Ma2024,
author = {Ma, Ying and Wang, Yiru and Wang, Can and Wang, Yan and Hu, Jingshu and Zhang, Zexue and Dong, Tuo and Chen, Xiuwei},
title = {miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition},
journal = {Discover Oncology},
year = {2024},
volume = {15},
number = {1},
doi = {10.1007/s12672-024-01106-w}
}
EUVIMED